Clomiphene 100 mg (Generic)

Product Overview

Clomiphene 100 mg represents a generic pharmaceutical formulation that has become a cornerstone in the management of female infertility, particularly among women diagnosed with ovulatory dysfunction such as polycystic ovary syndrome (PCOS) or idiopathic anovulation. Produced by HAB Pharmaceuticals & Research Ltd, this tablet strength delivers 100 mg of clomiphene citrate per unit, offering a standardized dose that aligns with many clinical protocols. The medication is packaged in blister strips containing ten tablets, and bulk purchase options are available in pack sizes of one hundred, two hundred, or three hundred tablets, providing flexibility for both short‑term trial periods and longer therapeutic courses. Shipping timelines typically range from six to fifteen days, ensuring that patients can commence treatment without prolonged delays. Clomiphene is recognized by major health authorities for its indication in stimulating ovulation and is listed in formularies for reproductive endocrinology. The product’s affordability, combined with its proven mechanism of action, makes it an attractive option for patients seeking a clinically validated fertility aid.

What is Clomiphene 100 mg?

Clomiphene citrate belongs to the class of selective estrogen receptor modulators (SERMs) and functions primarily as an estrogen antagonist in the hypothalamic region of the brain. By blocking estrogen receptors, the drug creates a physiological environment that the body interprets as low circulating estrogen levels. This perception triggers the hypothalamic‑pituitary axis to increase the secretion of follicle‑stimulating hormone (FSH) and luteinizing hormone (LH). Elevated FSH promotes the recruitment and maturation of multiple ovarian follicles, while the LH surge is responsible for triggering ovulation once a dominant follicle reaches sufficient size. The 100 mg dosage is one of the most commonly prescribed strengths in clinical practice, although the exact dose is individualized based on patient response, baseline hormonal profiles, and physician judgment. After oral administration, clomiphene undergoes hepatic metabolism, producing active metabolites that contribute to its prolonged pharmacological effect.

Uses and Benefits

The primary therapeutic use of Clomiphene 100 mg is the induction of ovulation in women who experience irregular or absent menstrual cycles due to ovulatory disorders. Clinical investigations have demonstrated that treatment regimens incorporating clomiphene can increase ovulation rates by up to 80 % in appropriately selected patients, with subsequent pregnancy rates that improve when ovulation is successfully achieved. In addition to its ovulatory effects, clomiphene offers several practical advantages: it is administered orally, eliminating the need for invasive procedures; it is relatively inexpensive compared with injectable gonadotropins; and it can be integrated into multimodal fertility strategies that may include lifestyle modifications, dietary adjustments, and assisted reproductive techniques such as intrauterine insemination (IUI). Moreover, the medication’s well‑characterized safety profile, when used under medical supervision, allows clinicians to prescribe it as a first‑line agent in many infertility work‑ups, reserving more invasive options for cases where ovulation induction fails.

How It Works

At the molecular level, clomiphene exerts its action by binding to estrogen receptors in the hypothalamus, where it antagonizes the effects of endogenous estrogen. This antagonism reduces negative feedback on the hypothalamic‑pituitary axis, leading to an up‑regulation of gonadotropin‑releasing hormone (GnRH) pulses. Consequently, the pituitary gland secretes increased amounts of FSH and LH into the systemic circulation. FSH stimulates the growth of multiple ovarian follicles, while LH, surging mid‑cycle, induces the final maturation and release of the dominant follicle’s oocyte. The selective nature of clomiphene’s receptor activity means that its agonist/antagonist effects vary across tissues, resulting in minimal impact on peripheral estrogenic pathways while still achieving the desired reproductive outcome. This mechanism underlies its efficacy in promoting the development of one or more mature follicles, thereby enhancing the probability of natural conception.

Dosage Guidelines

Standard dosing protocols for clomiphene typically begin with a daily oral dose of 50 mg administered for five consecutive days early in the menstrual cycle, commonly on days three through five. If ovulation does not occur after the initial cycle, the prescribing clinician may consider increasing the dose to 100 mg daily for up to three additional cycles, maintaining the same five‑day administration window. Some protocols allow for dose escalation to 150 mg in select cases, but such adjustments are made only under close medical oversight due to the heightened risk of ovarian hyperstimulation syndrome (OHSS) and multiple gestation. It is essential that patients adhere strictly to the prescribed schedule, take each tablet with water, and avoid exceeding the recommended duration of six cycles within a twelve‑month period. Throughout treatment, physicians often request hormonal monitoring and ultrasound assessments to evaluate follicular development and to tailor subsequent dosing decisions, ensuring both safety and efficacy.

Side Effects

Most individuals tolerate clomiphene well, with the majority of adverse events being mild and transient. Commonly reported side effects include hot flashes, abdominal bloating, breast tenderness, and occasional visual disturbances such as blurred vision or heightened sensitivity to bright light. Some patients may experience mood fluctuations, mild headaches, or nausea, which typically resolve upon discontinuation of the medication. Although rare, more serious complications can arise, including the development of ovarian cysts, pelvic discomfort, and, in exceptional circumstances, thromboembolic events or severe OHSS. Patients should be instructed to cease treatment and seek immediate medical attention if they experience intense abdominal pain, shortness of breath, chest pain, or any signs of an allergic reaction such as rash, itching, or swelling of the face and throat. Regular follow‑up appointments are recommended to monitor for these potential adverse outcomes.

Warnings and Precautions

Clomiphene is contraindicated in patients with known hypersensitivity to the drug, active liver disease, adrenal or pituitary gland disorders, and certain ovarian neoplasms. It must not be used during pregnancy, as fetal exposure can lead to abnormal sexual development, and it is also discouraged in lactating women due to the potential for passage into breast milk. Prior to initiation, a comprehensive medical evaluation should assess for conditions that could exacerbate treatment risks, including uterine fibroids, endometriosis, thyroid dysfunction, or uncontrolled hypertension. Concomitant use of drugs that influence hepatic enzyme activity, such as certain antifungals, antibiotics, or antiepileptics, may alter clomiphene metabolism and therefore requires dosage adjustments or alternative therapies. Women of reproductive age should employ effective contraception while undergoing treatment, unless pregnancy is the intended outcome and is being closely monitored by a healthcare professional. Ongoing surveillance through blood work and imaging is advised to track ovarian response and to mitigate the risk of overstimulation.

Frequently Asked Questions

1. Can I take Clomiphene 100 mg without a prescription? No. Clomiphene is a prescription medication that must be prescribed by a licensed healthcare professional after a proper evaluation of fertility status.
2. How many treatment cycles are recommended? Most clinicians limit therapy to a maximum of six cycles within a twelve‑month period to balance efficacy with the risk of ovarian hyperstimulation and to avoid unnecessary prolonged exposure.
3. Is Clomiphene effective for all types of infertility? It works best for women with ovulatory dysfunction such as PCOS, but may be less effective for male factor infertility, tubal blockage, or unexplained infertility without ovulatory issues.
4. What should I do if I miss a dose? If a scheduled dose is missed, take it as soon as remembered unless it is close to the time for the next dose; do not double the dose to catch up.
5. Are there dietary restrictions while using Clomiphene? No specific dietary restrictions are required, but maintaining a healthy weight and balanced nutrition can enhance ovulation rates and overall treatment success.

For more detailed scientific information, refer to resources such as the NIH, the FDA, and MedlinePlus. Additional consumer‑focused data can be found on Drugs.com.

Related Products

• Tretoin 0.1% Gel (Tretinoin)
• Tretoin 0.025% Cream (Tretinoin)
• Tretoin 0.05% Cream (Tretinoin)
• Tretinex Cream (Tretinoin)
• Tretoin Cream (Tretinoin)
• Naltrexone 50 mg (Naltrexone)
• Methylprednisolone (Signapred 4 mg)
• Signapred 4 mg (Methylprednisolone)
• Griseofulvin 500 mg (Generic)
• Lamifil 250 Mg (Terbinafine)
• Fungicyte 150 (Fluconazole 150mg)
• Dermozole 500 mg (Griseofulvin)